Clinical Trial Update: Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Becotatug Vedotin (MRG003) in previously treated advanced hepatocellular carcinoma; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Becotatug Vedotin

Snippet

Sponsor: Fudan University | Conditions: Hepato Cellular Carcinoma (HCC) | Phase 2 | Status: RECRUITING